Light Chain of Botulinum Neurotoxin Serotype A: Structural Resolution of a Catalytic Intermediate,
- 27 June 2006
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 45 (29) , 8903-8911
Abstract
Botulinum neurotoxin serotype A (BoNT/A, 1296 residues) is a zinc metalloprotease that cleaves SNAP25 to inhibit the fusion of neurotransmitter-carrying vesicles to the plasma membrane of peripheral neurons. BoNT/A is a disulfide-linked di-chain protein composed of an N-terminal, thermolysin-like metalloprotease light chain domain (LC/A, 448 residues) and a C-terminal heavy chain domain (848 residues) that can be divided into two subdomains, a translocation subdomain and a receptor binding subdomain. LC/A cleaves SNAP25 between residues Gln197−Arg198 and, unlike thermolysin, recognizes an extended region of SNAP25 for cleavage. The structure of a recombinant LC/A (1−425) treated with EDTA (No−Zn LC/A) was determined. The overall structure of No−Zn LC/A is similar to that reported for the holotoxin, except that it lacks the Zn ion, indicating that the role of Zn is catalytic not structural. In addition, structures of a noncatalytic mutant LC/A (Arg362Ala/Tyr365Phe) complexed with and without an inhibitor, ArgHX, were determined. The overall structure and the active site conformation for the mutant are the same as wild type. When the inhibitor binds to the active site, the carbonyl and N-hydroxyl groups form a bidentate ligand to the Zn ion and the arginine moiety binds to Asp369, suggesting that the inhibitor-bound structure mimics a catalytic intermediate with the Arg moiety binding at the P1‘ site. Consistent with this model, mutation of Asp369 to Ala decreases the catalytic activity of LC/A by ∼600-fold, and the residual activity is not inhibited by ArgHX. These results provide new information on the reaction mechanism and insight into the development of strategies for small molecule inhibitors of BoNTs.Keywords
This publication has 9 references indexed in Scilit:
- Expanding use of botulinum toxinJournal of the Neurological Sciences, 2005
- Synaptotagmins I and II Act as Nerve Cell Receptors for Botulinum Neurotoxin GJournal of Biological Chemistry, 2004
- Novel small molecule inhibitors of botulinum neurotoxin A metalloprotease activityBiochemical and Biophysical Research Communications, 2003
- Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cellsJournal of Cell Biology, 2003
- Botulinum neurotoxin types A and E require the SNARE motif in SNAP‐25 for proteolysisFEBS Letters, 1997
- Mechanism of action of tetanus and botulinum neurotoxinsMolecular Microbiology, 1994
- MOLSCRIPT: a program to produce both detailed and schematic plots of protein structuresJournal of Applied Crystallography, 1991
- Interaction of botulinum and tetanus toxins with the lipid bilayer surfaceBiochemical Journal, 1988
- Structure of thermolysin refined at 1.6 Å resolutionJournal of Molecular Biology, 1982